Cases 41 - 50 of 143
Janssen Pharmaceuticals, Inc., et al. v. Tolmar, Inc.
as 1:2021cv01784
Counter Defendant:
Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica NV
Counter Claimant:
Tolmar, Inc.
Defendant:
Tolmar Therapeutics, Inc., Tolmar Pharmaceuticals, Inc. and Tolmar Holding, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
as 22-1258
Plaintiff / Appellee:
JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant / Appellant:
TEVA PHARMACEUTICALS USA, INC., MYLAN LABORATORIES LIMITED and MYLAN LABORATORIES LTD.
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv01742
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 3:2021cv18609
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, L.L.C.
Defendant:
MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 35 U.S.C. § 145
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED
as 3:2021cv15137
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, LLC
Defendant:
MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Bayer Pharma AG et al v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv00099
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Pharma AG et al v. Taro Pharmaceutical Industries Ltd. et al
as 1:2021cv01000
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Pharma AG et al v. Teva Pharmaceuticals USA, Inc.
as 1:2021cv01001
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Bayer Pharma AG et al v. Dr. Reddys Laboratories, Ltd. et al
as 1:2021cv00732
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
